PF4 and neoplasm: Moreover, the CXCL4 variant CXCL4L1, isolated from thrombin-stimulated platelets and differing from authentic CXCL4 in three carboxy-terminally located amino acids, was found to be more potent than CXCL4 in inhibiting angiogenesis and tumor growth [26,27].